• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinoma.

作者信息

Weiss G R, Margolin K A, Sznol M, Atkins M B, Oleksowicz L, Isaacs R, Sosman J A, Doroshow J H, Trehu E G, Dutcher J P

机构信息

University of Texas Health Science Center at San Antonio, Division of Medical Oncology 78284-7884, USA.

出版信息

J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):52-6. doi: 10.1097/00002371-199507000-00007.

DOI:10.1097/00002371-199507000-00007
PMID:8535571
Abstract
摘要

相似文献

1
A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinoma.
J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):52-6. doi: 10.1097/00002371-199507000-00007.
2
Tumour stimulating effects of recombinant human interleukin-6.重组人白细胞介素-6的肿瘤刺激作用
Lancet. 1994 Dec 3;344(8936):1576-7. doi: 10.1016/s0140-6736(94)90387-5.
3
A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.一项关于持续输注白细胞介素-2或大剂量注射白细胞介素-2加淋巴因子激活的杀伤细胞用于晚期肾细胞癌的随机II期试验。
J Clin Oncol. 1992 Feb;10(2):275-81. doi: 10.1200/JCO.1992.10.2.275.
4
[Combination therapy with interferon-alpha and continuous infusion of 5-fluorouracil for advanced renal cell carcinoma].α-干扰素与5-氟尿嘧啶持续输注联合治疗晚期肾细胞癌
Hinyokika Kiyo. 1995 Jul;41(7):517-20.
5
Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies.
Cancer Treat Rev. 1989 Jun;16 Suppl A:83-9. doi: 10.1016/0305-7372(89)90027-3.
6
[Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
Urologe A. 1995 Mar;34(2):158-61.
7
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.高剂量α-2b干扰素与白细胞介素-2大剂量推注隔日交替给药治疗转移性肾细胞癌：一项II期研究
Cancer. 1993 Sep 1;72(5):1733-42. doi: 10.1002/1097-0142(19930901)72:5<1733::aid-cncr2820720537>3.0.co;2-x.
8
Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.白细胞介素-2（IL2）用于转移性肾细胞癌和黑色素瘤的两项连续II期研究结果：大剂量持续静脉输注IL2以及皮下注射IL2联合α干扰素。
Rev Med Univ Navarra. 1996 Jul-Sep;40(3):6-12.
9
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic renal cell carcinoma: a phase II trial of the National Biotherapy Study Group.转移性肾细胞癌患者采用高剂量推注/持续输注白细胞介素-2混合疗法：国家生物治疗研究组的一项II期试验
Cancer Biother Radiopharm. 1997 Feb;12(1):5-11. doi: 10.1089/cbr.1997.12.5.
10
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.白细胞介素-2与淋巴因子激活的杀伤细胞治疗肾细胞癌：推注与持续输注白细胞介素-2联合方案的II期经验
J Clin Oncol. 1990 Oct;8(10):1630-6. doi: 10.1200/JCO.1990.8.10.1630.

引用本文的文献

1
Landscape of Immunotherapy in Genitourinary Malignancies.泌尿生殖系统恶性肿瘤的免疫治疗全景。
Adv Exp Med Biol. 2021;1342:143-192. doi: 10.1007/978-3-030-79308-1_5.
2
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines.肾癌：细胞因子工作组经验（1986 - 2001年）：第二部分。白细胞介素-2毒性的管理及其他细胞因子的研究
Med Oncol. 2001;18(3):209-19. doi: 10.1385/MO:18:3:209.
3
Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.
白细胞介素-2/α-干扰素-2联合5-氟尿嘧啶治疗肾细胞癌患者时免疫监测的预后价值
Urol Res. 1996;24(5):297-303. doi: 10.1007/BF00304780.